Targeted PT market EuMotus offers a move-analysis solution tailored for physical therapists, highlighting strong potential to upsell to PT clinics seeking evidence-based practice, improved patient retention, and new patient attraction.

Low headcount agility With a small team of 2-10 employees, EuMotus likely favors scalable, low-friction sales channels, channel partnerships, and outbound outreach that emphasizes quick trials and fast ROI for clinics.

Markerless edge The 3D markerless motion analysis capability, rapid one-minute assessments, and no complex setup differentiate EuMotus from traditional motion capture, creating a compelling value proposition for clinics seeking efficiency and objective insights.

Early-stage traction Being an AngelPad 11 startup with revenue under $1M suggests an opportunity to position as a high-potential vendor for early adopters, with emphasis on case studies, pilot programs, and flexible pricing models.

Competitive landscape EuMotus operates in a space with established players (Rokoko, Xsens, Vicon, etc.) but targets a niche in clinical PT settings; sales messaging can focus on clinic-readiness, CEU education integrations, and real-world clinical outcomes to win share.